100 related articles for article (PubMed ID: 35832470)
1. Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.
Baio R; Napodano G; Caruana C; Molisso G; Di Mauro U; Intilla O; Pane U; D'Angelo C; Francavilla AB; Guarnaccia C; Pentimalli F; Sanseverino R
Mol Clin Oncol; 2022 Aug; 17(2):127. PubMed ID: 35832470
[TBL] [Abstract][Full Text] [Related]
2. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
Liang Y; Ankerst DP; Sanchez M; Leach RJ; Thompson IM
Urology; 2010 Nov; 76(5):1268.e1-6. PubMed ID: 20739049
[TBL] [Abstract][Full Text] [Related]
3. Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort.
Tang B; Han CT; Zhang GM; Zhang CZ; Yang WY; Shen Y; Vidal AC; Freedland SJ; Zhu Y; Ye DW
Sci Rep; 2017 Mar; 7():43551. PubMed ID: 28272469
[TBL] [Abstract][Full Text] [Related]
4. Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia.
Kim JM; Song PH; Kim HT; Moon KH
Korean J Urol; 2011 Jun; 52(6):401-5. PubMed ID: 21750751
[TBL] [Abstract][Full Text] [Related]
5. Gleason score stratification according to age at diagnosis in 1028 men.
Pepe P; Pennisi M
Contemp Oncol (Pozn); 2015; 19(6):471-3. PubMed ID: 26843845
[TBL] [Abstract][Full Text] [Related]
6. Multivariate logistic regression analysis of the clinical factors influencing locally advanced prostate cancer.
Ke Z; Xu Y; Shu Y; Wang C; Wu B; Zhang B; Xiang P; Hu X
Transl Cancer Res; 2024 Feb; 13(2):676-685. PubMed ID: 38482405
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Prostate Cancer in Organ Donors With Increased Prostate-Specific Antigen.
Bzoma B; Dębska-Ślizień A; Rościńska P; Piątkowski K; Kostro J; Łukiański M; Bigda J; Chamienia A
Transplant Proc; 2024 May; ():. PubMed ID: 38724405
[TBL] [Abstract][Full Text] [Related]
8. Predicting the resected tissue weight from a digital rectal examination and total prostate specific antigen level before transurethral resection of the prostate.
Harraz AM; El-Assmy A; Tharwat M; Elshal AM; El-Nahas AR; Barakat TS; Elsaadany MM; El-Halwagy S; Ibrahiem el HI
Arab J Urol; 2014 Dec; 12(4):256-61. PubMed ID: 26019959
[TBL] [Abstract][Full Text] [Related]
9. Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial.
Van Der Eecken H; Vansevenant B; Devos G; Roussel E; Giesen A; Darras J; Ameye F; Van Wynsberge L; Goeman L; Claessens M; Ost D; Joniau S
Urology; 2024 Apr; ():. PubMed ID: 38670272
[TBL] [Abstract][Full Text] [Related]
10. A cost-benefit analysis of mass prostate cancer screening.
Farabi H; Moradi N; Ahmadzadeh A; Aghamir SMK; Mohammadi A; Rezapour A
Cost Eff Resour Alloc; 2024 May; 22(1):37. PubMed ID: 38705990
[TBL] [Abstract][Full Text] [Related]
11. Physical activity assessment among men undergoing genetic counseling for inherited prostate cancer: a teachable moment for improved survivorship.
Bruneau M; Milliron BJ; Sinclair E; Obeid E; Gross L; Bealin L; Smaltz C; Butryn M; Giri VN
Support Care Cancer; 2021 Apr; 29(4):2145-2151. PubMed ID: 32876733
[TBL] [Abstract][Full Text] [Related]
12. Association of body mass index with clinical outcome of primary WHO grade 4 glioma.
Wang J; Hao Z; Li R; Wu W; Huang N; Zhang K; Hao S; Feng J; Chu J; Ji N
Front Oncol; 2024; 14():1318785. PubMed ID: 38741777
[TBL] [Abstract][Full Text] [Related]
13. Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk.
Xiao J; Howard L; Wan J; Wiggins E; Vidal A; Cohen P; Freedland SJ
Oncotarget; 2017 Nov; 8(55):94900-94909. PubMed ID: 29212276
[TBL] [Abstract][Full Text] [Related]
14. Exposure to environmental pollutants and genetic variants related to oxidative stress and xenobiotic metabolism-Association with prostate cancer.
Álvarez-González B; Hernández AF; Zafra-Gómez A; Chica-Redecillas L; Cuenca-López S; Vázquez-Alonso F; Martínez-González LJ; Álvarez-Cubero MJ
Environ Toxicol Pharmacol; 2024 Apr; 108():104455. PubMed ID: 38657881
[TBL] [Abstract][Full Text] [Related]
15. Eight-year survival and continuation of therapy in a patient suffering from prostate cancer with metastases and pathological fractures of vertebrae.
Dutkiewicz S; Poniatowska R
Cent European J Urol; 2011; 64(2):97-9. PubMed ID: 24578875
[TBL] [Abstract][Full Text] [Related]
16. Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact.
Santos-Pereira M; Pereira SC; Rebelo I; Spadella MA; Oliveira PF; Alves MG
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068717
[TBL] [Abstract][Full Text] [Related]
17. Prostate Biopsy in the Case of PIRADS 5-Is Systematic Biopsy Mandatory?
Malewski W; Milecki T; Szempliński S; Tayara O; Kuncman Ł; Kryst P; Nyk Ł
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685679
[TBL] [Abstract][Full Text] [Related]
18. Associations between Body Mass Index and Prostate Cancer: The Impact on Progression-Free Survival.
Popovici D; Stanisav C; Pricop M; Dragomir R; Saftescu S; Ciurescu D
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837490
[No Abstract] [Full Text] [Related]
19. Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting.
Pejčić T; Todorović Z; Đurašević S; Popović L
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769263
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Support for the Treatment of Obesity-Present and Future.
Kosmalski M; Deska K; Bąk B; Różycka-Kosmalska M; Pietras T
Healthcare (Basel); 2023 Feb; 11(3):. PubMed ID: 36767008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
